Molecular epidemiology, pathogenesis and prevention of gastric cancer

被引:161
作者
Stadtländer, CTKH [1 ]
Waterbor, JW [1 ]
机构
[1] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol & Int Hlth, Birmingham, AL 35294 USA
关键词
D O I
10.1093/carcin/20.12.2195
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer of the stomach is one of the most commonly diagnosed malignancies and remains an important cause of mortality world wide. This type of cancer is not uniformly distributed among populations but shows a marked variation in both incidence and mortality. Although gastric cancer is declining in many parts of the world, the reasons for this decline are not well understood and its etiology remains unclear. Several factors are suspected to play a role in gastric carcinogenesis, including the effects of diet, exogenous chemicals, intragastric synthesis of carcinogens, genetic factors, infectious agents and pathological conditions in the stomach (such as gastritis), A new look at the results of epidemiological and experimental studies is important for the establishment of strategies for control. Since cancer of the stomach has a very poor prognosis in its more advanced stages, such a control program must have its main focus on primary prevention, This review describes our knowledge about cancer of the stomach regarding epidemiology, pathogenesis and prevention.
引用
收藏
页码:2195 / 2207
页数:13
相关论文
共 141 条
[1]  
[Anonymous], 1995, IARC SCI PUBLICATION
[2]  
[Anonymous], 1999, SEER CANC STAT REV 1
[3]  
[Anonymous], 1994, INFECT HELICOBACTER, V61, P177
[4]   Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer [J].
Aromaa, A ;
Kosunen, TU ;
Knekt, P ;
Maatela, J ;
Teppo, L ;
Heinonen, OP ;
Harkonen, M ;
Hakama, MK .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 144 (02) :142-149
[5]   MUTAGENICITY OF NITRIC-OXIDE AND ITS INHIBITION BY ANTIOXIDANTS [J].
ARROYO, PL ;
HATCHPIGOTT, V ;
MOWER, HF ;
COONEY, RV .
MUTATION RESEARCH, 1992, 281 (03) :193-202
[6]  
Atherton JC, 1998, BRIT MED BULL, V54, P105
[7]  
BARRANCO SC, 1983, CANCER RES, V43, P1703
[8]   ENDOGENOUSLY FORMED N-NITROSO COMPOUNDS AND NITROSATING AGENTS IN HUMAN CANCER ETIOLOGY [J].
BARTSCH, H ;
OHSHIMA, H ;
PIGNATELLI, B ;
CALMELS, S .
PHARMACOGENETICS, 1992, 2 (06) :272-277
[9]   DEVELOPMENT OF INVITRO SYSTEMS FOR CHEMOPREVENTION RESEARCH [J].
BERTRAM, JS ;
HOSSAIN, MZ ;
PUNG, A ;
RUNDHAUG, JE .
PREVENTIVE MEDICINE, 1989, 18 (05) :562-575
[10]   Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990 [J].
Black, RJ ;
Bray, F ;
Ferlay, J ;
Parkin, DM .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) :1075-1107